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Introduction Parkinson’s disease (PD) is the second most common neurodegenerative 
disease after Alzheimer’s disease (AD) and the most frequent sub-cortical 
degenerative disease, characterized by universal progressive disorder of the 
nervous system that affects movement. This cross sectional study aimed to 
determine the prevalence and correlates of PD among elderly attending the 
neurology clinic in Serdang Hospital.  
Methods A total of 150 records of patients attended the clinic from January to 
December 2016 were randomly selected. Data was collected using a 
proforma form seeking information related to age, gender, race, locality, and 
presence of comorbidity particularly diabetes mellitus. The data was analysed 
using the Statistical Package for Social Science (IBM SPSS) version 22.0.  
Results The prevalence of PD among the elderly involved in the study was 34%. 
Majority of the respondents were aged 60 to 70 years old (54.7%), male 
(53.3%), Chinese (56.7%), from urban locality (93.0%) and were not diabetic 
(69.3%). The inferential statistics showed no significant association between 
all the factors with PD. However, the associations between age and diabetes 
mellitus with PD were almost significant with p values of 0.07 and 0.08 
respectively.  
Conclusions Overall, the prevalence of PD among elderly who attended the neurology 
clinic in year 2016 was less than half with none of the factors under study 
were significantly associated with PD. However with bigger sample size, 
possible significant association may be obtained between age and diabetes 
mellitus.  
Keywords Prevalence - Correlates - Parkinson’s Disease - Elderly. 
 
 
  
PUBLIC HEALTH RESEARCH 
International Journal of Public Health Research Vol 8 No 1 2018, pp (894-898) 
895 
INTRODUCTION 
Parkinson's disease (PD) is a progressive 
neurological disorder which commonly occurs in 
the ageing brain. It is associated with impaired and 
dead neurons in the brain. Being the second most 
common neurodegenerative disease after 
Alzheimer's disease (AD), it is the most frequent 
subcortical degenerative disease. It has been 
suggested that, PD is not caused by an acceleration 
of a naturally occurring aging process1 because the 
numbers of midbrain catecholaminergic neurons do 
not significantly decline in very old subjects 
without PD (aged >80 years). This was also 
supported by numerous epidemiological studies 
which reported a decline in the incidence of PD 
after the age of 70 to 75 years2 and have also 
shown that PD is not a frequent primary cause of 
mortality for those older than 85 years.3  
According to the Parkinson’s Disease 
Foundation,4 more than 10 million people 
worldwide are living with Parkinson's disease. 
Approximately 60,000 Americans are diagnosed 
with Parkinson's disease each year, and this number 
does not reflect the thousands of cases that go 
undetected.4 Although incidence of Parkinson’s 
increases with age, but an estimated four percent of 
people with PD are diagnosed before the age of 50. 
A systematic review conducted by Hirsch et al.5 of 
related studies between 2001 and 2014 revealed 
rising incidence of PD with age in both men and 
women. While males had a higher incidence of PD 
in all age groups, this difference was only 
statistically significant for those in the age range 
60-69 and 70-79 (p < 0.05). 
Symptoms of PD begin to appear when 
about 80% of the related neurons become damaged 
or impaired. These symptoms will continue and 
often worsen over time. Persistent body tremor is 
the most common symptom of PD, especially 
among the elderly. Tremors are often the first 
symptom and the least disabling, but often cause 
the most embarrassment for the patient in public. 
The slowness of movement that is also common in 
PD as the disease progresses is called bradykinesia, 
which is one of the cardinal manifestations of PD. 
Usually the early symptoms are quite mild and 
often do not require medication. The physical 
changes associated with PD impact the most 
routine habits like getting dressed or rising from a 
chair. Numerous age-related factors have been 
advanced as influences on parkinsonism which 
include overlap between signs of senescence and 
parkinsonian signs, confounding comorbidities, 
loss of therapeutic efficacy because of age-related 
altered pharmacokinetics and pharmacodynamics, 
and increasing prevalence of non-dopaminergic 
lesions, causing drug-resistant motor impairment.6  
Parkinson's disease in the elderly is not 
easily diagnosed. Neither x-rays nor blood tests 
reveal the condition. Blood tests and magnetic 
resonance imaging (MRI) can be used to eliminate 
other conditions. PD is a treatable disorder and 
drug therapy can be very gratifying for both the 
patients and clinicians. However, once the disease 
progresses, the benefits become less complete and 
eventually additional problems surface that are 
poorly or incompletely treatable. The massive 
variability among patients in how the disease 
progresses, makes it very difficult to accurately 
predict how quickly symptoms will worsen, or 
even which specific symptoms will develop for 
each patient, which make PD in the elderly a 
difficult disease to diagnose properly. This study 
aimed to determine the prevalence and factors that 
are associated with PD among the elderly people 
attending the neurology clinic at a public hospital 
in Malaysia. 
 
METHODS 
This study is a cross sectional study using a 
hospital-based secondary data. A list of elderly 
patients aged 60 years old and above attended the 
neurology clinic in Serdang Hospital, Selangor 
from January to December 2016 was identified. A 
proforma was developed for the purpose of data 
collection, seeking information related to the 
diagnosis of PD, age, gender, ethnicity, locality and 
presence of other comorbidity specifically diabetes 
mellitus was developed prior to data collection. 
The initial proforma contained numerous other 
factors which include weight. However, due to 
massive incomplete data reported in the system and 
further discussion with neurologist incharged, 
several factors were excluded. Based on the list of 
names obtained, 150 samples were selected using 
simple random sampling. The data was entered and 
analysed using IBM SPSS statistic version 22.0. 
The significance level was set at p<0.05. Normality 
testing was conducted for continuous data such as 
age prior to analysis.  
 
RESULTS 
The results revealed only 34% of the respondents 
were found to have PD. Majority of the 
respondents were aged 60 to 70 years old (54.7%), 
male (53.3%), Chinese (56.7%), comes from urban 
locality (93.3%) and did not have diabetes mellitus 
(69.3%) as shown in table 1. Meanwhile, table 2 is 
showing the factors associated with PD among the 
elderly people who were selected for the study. 
None of the factors included in the study were 
significantly associated with PD. However, age and 
diabetes mellitus were almost having significant 
association with p values of 0.070 and 0.083 
respectively. 
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Table 1 Socio-demographic characteristics of respondents (N=150) 
 
Factors n (%) 
Age 
60-70 
71 and above 
Gender 
Male 
Female 
Race 
Malay 
Chinese 
Indian 
Locality 
Urban 
Rural 
Diabetes Mellitus 
Yes 
No 
 
82 (54.7) 
68 (45.3) 
 
80 (53.3) 
70 (46.7) 
 
47 (31.3) 
85 (56.7) 
18 (12.0) 
 
140 (93.3) 
10 (6.7) 
 
46 (30.7) 
104 (69.3) 
 
Table 2 Factors associated with Parkinson’s Disease (N=150) 
 
Factors Parkinson’s disease (%) P-value 
χ2 Yes No 
Age  
60-70 
71 and above 
 
23 (27.7) 
28 (41.8) 
 
60 (72.3) 
39 (58.2) 
 
0.070 
Gender 
Male 
Female 
 
28 (35.0) 
23 (32.9) 
 
52 (65.0) 
47 (67.1) 
 
0.782 
Race 
Malay 
Chinese 
Indian 
 
15 (31.9) 
31 (36.5) 
5 (27.8) 
 
32 (68.1) 
54 (63.5) 
13 (72.2) 
 
0.730 
Locality 
Urban 
Rural 
 
47 (33.6) 
4 (40.0) 
 
93 (66.4) 
6 (60.0) 
 
0.735 
Diabetes mellitus 
Yes 
No 
 
11 (23.9) 
40 (38.5) 
 
35 (76.1) 
64 (61.5) 
 
0.083 
 
DISCUSSION 
Characterized by body tremors, stiffness and 
difficulty moving, PD is a neurological disease that 
is often difficult to diagnose in the elderly. The 
prevalence estimates of PD vary widely across 
studies and countries and are inconsistent in some 
countries that lead to the conduction of systematic 
reviews of prevalence of PD. The findings of this 
study revealed that among the elderly patients who 
attended the neurology clinic for various reasons, 
34% of them were found to have PD. A lower 
prevalence may be expected if the study was 
conducted among the community dwelling elderly 
rather that in a hospital setting. Several previous 
studies reported lower prevalence of PD and 
minimal difference between male and female. A 
study by Tison et al.7 on the prevalence of PD 
among 3149 people over age 65 reported a very 
low prevalence of only 1.4%, with no significant 
difference between older men and women. 
Similarly, another study which was conducted 
about the same time among general elderly 
population in the Netherlands also reported a low 
prevalence of PD which was 1.4% (1.2% for men, 
1.5% for women).8 However, these two studies 
were conducted more than 20 years ago and the 
comparable recent prevalence maybe more 
accurate. Meanwhile, there was also studies 
reported high prevalence of PD. A recent study 
among the Navajo people living in the Navajo 
nation on incidence and prevalence of PD revealed 
a high prevalence of PD among the general 
population with 524 of the Navajo people with 
median age-at-onset of 74.0 years were diagnosed 
with PD during the study period, yielding an 
average annual crude incidence rate of 
22.5/100,000.9 
International Journal of Public Health Research Vol 8 No 1 2018, pp (894-898) 
897 
This study also found that, although none 
of the factors were significantly associated with 
PD, significant relationship could be obtained 
between age and presence of diabetes mellitus if a 
bigger sample size is used. The increase in the 
prevalence of PD with age has been reported in 
many studies. Van de Vijver et al.10 in their study 
which was also using secondary data from the 
pharmacy records involving residents of six Dutch 
cities revealed, the unadjusted prevalence (per 
100,000) for those aged 55-64 years was 111, 65-
74 years 598, 75-84 years 1551 and for persons 
aged 85 years and older 1847, which indicate a 
positive linear relationship between PD and age. 
Another similar finding was also shown in a study 
by De Rijk et al.8 with the prevalence of 0.3% for 
those aged 55 to 64 years, 1.0% for those 65 to 74, 
3.1% for those 75 to 84, and 4.3% for those 85 to 
94. The corresponding age-specific figures for men 
were 0.4%, 1.2%, 2.7%, and 3.0%, and for women, 
0.2%, 0.8%, 3.4%, and 4.8%.8 Additionally, in a 
collaborative study involving 5 European 
populations also reported that the prevalence of 
parkinsonism and PD increased with age in all five 
surveys for both men and women, with no decrease 
at higher ages. This suggests that the prevalence, 
and probably also the incidence, of PD continues to 
increase beyond the age 85 or 90 years.11 
As for the presence of diabetes mellitus, 
an almost significant relationship was also obtained 
from this study. Changes in human behaviour and 
lifestyle have globally increased the prevalence of 
diabetes mellitus (DM) which closely related to 
mitochondrial function. Many diseases of 
mitochondrial dysfunction affect more than 1 
system in the human body, and commonly affect 
organs that require a lot of energy, including the 
heart, skeletal muscle, and brain. A study by 
Schapira12 on specific gene mutations that cause 
PD has reinforced the relevance of oxidative stress 
and mitochondrial dysfunction in the familial and 
the sporadic forms of the disease. The result of the 
study indicates that the PD associated proteins are 
either mitochondrial proteins or associated with 
mitochondria, and all interface with the pathways 
of oxidative stress and free radical damage. Many 
studies in the literature indicate that PD and DM, 
both age-related chronic diseases, share remarkably 
similar pathways of mitochondrial dysfunction and 
suggest the association of DM with PD.13-14 The 
relationship between DM and PD was inconsistent 
with several epidemiological reports. A meta-
analysis study from 14 reports and concluded that 
evidence from case-control studies suggested that 
diabetic individuals may have a decreased 
incidence of PD despite significant heterogeneity.15 
Meanwhile, in the other meta-analysis exploring 
this line of question including cohort and case-
control studies, the pooled results of 4 cohort 
studies with large sample size demonstrated that 
diabetes was associated with a significant 37% 
increased risk of PD.16 To clarify the role of type 2 
DM on the risk of PD incidence, a large cohort 
study of Chinese patients with and without type 2 
DM in Taiwan was conducted by Yang et al.17 
which revealed DM increased the risk of PD during 
a mean follow-up of 7.3 years. 
 
CONCLUSION 
This study revealed a high prevalence of PD among 
elderly attending the neurology clinic. However, a 
comparable study among the community dwelling 
elderly would be necessary. Further study should 
be conducted to explore the relationship between 
age and diabetes mellitus with PD among the 
Malaysian population. Among the limitations of 
this study that should be taken into future 
considerations are the small sample size. Another 
limitation is the use of cross sectional study design 
which does not take into account the temporal 
effect.  
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